Rapport: "Embryonale stamceller". - Teknologirådet

More documents

Recommendations

Info

Embryonale stamceller – høring om anvendelse af stamceller i forskning og behandling 23. januar 2003 Embryonale stamceller - høring om anvendelse af stamceller i forskning og behandling Resumé og redigeret udskrift af høring i Folketinget den 23. januar 2003 Projektledelse i Teknologirådets sekretariat Laura Zurita, projektleder Projektmedarbejder: Jacob Skjødt Nielsen Projektsekretær: Jette Christensen Resumé Anne Birkelund, journalist Redigeret udskrift LanguageWire og Teknologirådet Omslag Bysted HQ A/S Tryk Vester Kopi A/S ISBN 87-90221-82-6 ISSN: 1395 – 7392 Rapporten bestilles hos Teknologirådet Antonigade 4 1106 København K Telefon 33 32 05 03 Fax 33 91 05 90 tekno@tekno.dk Rapporten findes også på BIOSAMs hjemmeside www.biosam.dk Teknologirådets rapporter 2003/1
Embryonale stamceller – høring om anvendelse af stamceller i forskning og behandling 23. januar 2003 Indholdsfortegnelse FORORD...........................................................................................................................................................................1 RESUMÉ...........................................................................................................................................................................2 HVAD ER STAMCELLER?....................................................................................................................................................2 TRE SKRIDT FREM OG TO TILBAGE ......................................................................................................................................2 ANTALLET AF BEFRUGTEDE ÆG..........................................................................................................................................3 VOKSNE ELLER EMBRYONALE STAMCELLER .........................................................................................................................3 INDIVIDUELT MENNESKELIGT LIV ......................................................................................................................................4 TINGSLIGGØRELSE AF LIV..................................................................................................................................................4 FORSKELLIGE LOV-MODELLER............................................................................................................................................5 INTERESSER OG RETTIGHEDER ...........................................................................................................................................5 DET FORSKNINGSMÆSSIGE POTENTIALE.............................................................................................................................6 BETACELLER TIL DIABETES.................................................................................................................................................7 SPØRGSMÅL OM RISICI .....................................................................................................................................................7 DEBAT OM MENNESKELIGT LIV .........................................................................................................................................8 DE ERHVERVSMÆSSIGE PERSPEKTIVER...............................................................................................................................8 PATENT PÅ CELLELINIER....................................................................................................................................................9 GRUNDFORSKNING ELLER BEHANDLING ............................................................................................................................9 DE SUNDHEDSMÆSSIGE PERSPEKTIVER............................................................................................................................10 ET LANDSDÆKKENDE REGISTER.......................................................................................................................................10 DEBAT OM RESSOURCER .................................................................................................................................................11 DE SAMFUNDSMÆSSIGE RAMMER...................................................................................................................................12 UDVIDELSE AF ETIK-BEGREBET........................................................................................................................................12 BÅDE FOREBYGGELSE OG BEHANDLING............................................................................................................................13 KILDEN TIL STAMCELLER.................................................................................................................................................14 REDIGERET UDSKRIFT AF HØRING OM EMBRYONALE STAMCELLER ............................................................. 15 VELKOMST....................................................................................................................................................................15 HELGE SANDER, MINISTER FOR VIDENSKAB, TEKNOLOGI OG UDVIKLING: VIDEN OM STAMCELLER ............................................................................................................................................17 STEN EIRIK JACOBSEN, PROFESSOR, MD, PH.D, LUND UNIVERSITET:.................................................................................17 PETER HOKLAND, OVERLÆGE, DR.MED., ÅRHUS AMTSSYGEHUS: ......................................................................................19 DE ETISKE OG REGULERINGSMÆSSIGE SPØRGSMÅL............................................................................................29 SVEND ANDERSEN, PROFESSOR, DR.THEOL., CENTER FOR BIOETIK, AARHUS UNIVERSITET: .................................................29 KERSTIN HOFFMAN, CAND.MED., LANDSSEKRETÆR FOR FORENINGEN RETTEN TIL LIV: .......................................................31 METTE HARTLEV , LEKTOR, PH.D., KØBENHAVNS UNIVERSITET, NÆSTFORMAND I DET ETISKE RÅD: ...................................33 DET FORSKNINGSMÆSSIGE POTENTIALE...............................................................................................................44 JENS ZIMMER RASMUSSEN, PROFESSOR DR.MED., DANSK CENTER FOR STAMCELLEFORSKNING: ..........................................44 OLE MADSEN, FORSKNINGSCHEF, PH.D., HAGEDORN RESEARCH INSTITUTE: .....................................................................47 DE ERHVERVSMÆSSIGE PERSPEKTIVER..................................................................................................................62 MADS KROGSGAARD THOMSEN, FORSKNINGSDIREKTØR, PROFESSOR, DR.MED.VET., NOVO NORDISK .................................62 METTE KIRSTINE AGGER, ADMINISTRERENDE DIREKTØR, 7TM PHARMA: .........................................................................65
Page 1: Embryonale stamceller - høring om
Page 5 and 6: Embryonale stamceller - høring om
Page 53 and 54:
Embryonale stamceller - høring om
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Contents Introduction p. 1 The biol
Page 193 and 194:
Hence, to get embryos that are surp
Page 195 and 196:
4. There are major differences in t
Page 197 and 198:
Country Reproductive cloning preven
Page 199:
show all

Rapport: "Embryonale stamceller". - Teknologirådet

Create successful ePaper yourself

Delete template?

Save as template?